1. Home
  2. SQNS vs ATYR Comparison

SQNS vs ATYR Comparison

Compare SQNS & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$5.32

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.72

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
ATYR
Founded
2003
2005
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
69.2M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
SQNS
ATYR
Price
$5.32
$0.72
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$21.33
$8.75
AVG Volume (30 Days)
206.8K
1.5M
Earning Date
02-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,534,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$70.61
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
3.20
N/A
52 Week Low
$4.44
$0.64
52 Week High
$58.30
$7.29

Technical Indicators

Market Signals
Indicator
SQNS
ATYR
Relative Strength Index (RSI) 49.60 46.66
Support Level $5.13 $0.69
Resistance Level $5.50 $0.76
Average True Range (ATR) 0.27 0.04
MACD 0.07 0.00
Stochastic Oscillator 48.55 53.27

Price Performance

Historical Comparison
SQNS
ATYR

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: